BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 25387733)

  • 1. Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor.
    Wang F; Jia Y; Tong Z
    Jpn J Clin Oncol; 2015 Feb; 45(2):146-52. PubMed ID: 25387733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcomas and malignant phyllodes tumours of the breast--a retrospective study.
    Confavreux C; Lurkin A; Mitton N; Blondet R; Saba C; Ranchère D; Sunyach MP; Thiesse P; Biron P; Blay JY; Ray-Coquard I
    Eur J Cancer; 2006 Nov; 42(16):2715-21. PubMed ID: 17023158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesenchymal breast sarcomas. Apropos of 25 cases].
    Spielmann M; Toussaint C; Malcoste G; Le Chevalier T; Mondésir JM; Contesso G; Sarrazin D; Genin J; Rouesse J
    Bull Cancer; 1985; 72(3):202-9. PubMed ID: 3000484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic analysis of benign, borderline and malignant phyllodes tumors of the breast].
    Wang H; Wang X; Wang C
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):923-7. PubMed ID: 26887622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the treatment and prognosis of recurrent breast phyllodes tumor].
    Fang Y; Gao JD; Tian YT; Xie YQ; Zhen S
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):72-4. PubMed ID: 19538877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
    Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
    Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary breast sarcomas: About 30 cases treated at Salah-Azaiez institute in Tunisia].
    El Amine Elhadj O; Nasri M; Thabet S; Ben Hassouna J; Goucha A; Rahal K; Elmay A; Gamoudi A
    Cancer Radiother; 2017 Feb; 21(1):45-50. PubMed ID: 28223032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas.
    Fajdić J; Gotovac N; Hrgović Z; Kristek J; Horvat V; Kaufmann M
    Onkologie; 2007 Mar; 30(3):113-8. PubMed ID: 17341897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Malignant Phyllodes Tumors of the Breast: Characteristics and Outcomes Based on the Surveillance Epidemiology and End Results Database.
    Xiao Y; Jiang Y; Xiong Y; Ruan S; Huang T
    J Surg Res; 2020 May; 249():205-215. PubMed ID: 31991330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors.
    Abe M; Miyata S; Nishimura S; Iijima K; Makita M; Akiyama F; Iwase T
    Breast Cancer; 2011 Oct; 18(4):268-72. PubMed ID: 22121516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical perspectives and outcomes of the giant breast phyllodes tumor and sarcoma: a real-world retrospective study.
    Liu N; Kang Y; Qu N; Kong C; Han Y
    BMC Cancer; 2023 Aug; 23(1):801. PubMed ID: 37635229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rare breast tumors].
    Haberthür F; Torhorst J; Feichter GE
    Ther Umsch; 1993 May; 50(5):359-65. PubMed ID: 8397448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant phyllodes tumor of the breast: treatment and prognosis.
    Mituś J; Reinfuss M; Mituś JW; Jakubowicz J; Blecharz P; Wysocki WM; Skotnicki P
    Breast J; 2014; 20(6):639-44. PubMed ID: 25227987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.
    Wang H; Wang X; Wang CF
    Asian Pac J Cancer Prev; 2014; 15(24):10791-5. PubMed ID: 25605178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of 78 breast sarcoma patients without distant metastases at presentation.
    McGowan TS; Cummings BJ; O'Sullivan B; Catton CN; Miller N; Panzarella T
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):383-90. PubMed ID: 10661345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of a Malignant Phyllodes Tumor That Was Difficult to Distinguish from Stromal Sarcoma].
    Goto W; Kashiwagi S; Takada K; Asano Y; Morisaki T; Noda S; Takashima T; Onoda N; Hirakawa K; Ohira M
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2429-2431. PubMed ID: 30692487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phyllodes tumors of the breast: a case series of 106 patients.
    Ben Hassouna J; Damak T; Gamoudi A; Chargui R; Khomsi F; Mahjoub S; Slimene M; Ben Dhiab T; Hechiche M; Boussen H; Rahal K
    Am J Surg; 2006 Aug; 192(2):141-7. PubMed ID: 16860620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary treatment of cystosarcoma phyllodes of the breast.
    Chaney AW; Pollack A; McNeese MD; Zagars GK; Pisters PW; Pollock RE; Hunt KK
    Cancer; 2000 Oct; 89(7):1502-11. PubMed ID: 11013364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
    Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
    Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.
    Rodrigues MF; Truong PT; McKevitt EC; Weir LM; Knowling MA; Wai ES
    Cancer Radiother; 2018 Apr; 22(2):112-119. PubMed ID: 29523388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.